Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 7/2003

01-07-2003 | Article

Incidence, prevalence and coronary heart disease risk level in known Type 2 diabetes: a sentinel practice network study in the Basque Country, Spain

Authors: Dr. J. M. Arteagoitia, M. I. Larrañaga, J. L. Rodriguez, I. Fernandez, J. A. Piniés

Published in: Diabetologia | Issue 7/2003

Login to get access

Abstract

Aims/hypothesis

The aim of this study was to determine the incidence, prevalence and coronary heart disease risk in patients with known Type 2 (non-insulin-dependent) diabetes mellitus in a Basque Country sentinel practice network study.

Methods

During the year 2000 we did a survey among sentinel practitioners who registered information about previously and newly diagnosed Type 2 diabetic patients older than 24 years of age. We studied 65,651 people attending a primary care service in the Basque Country Health Service-Osakidetza. We collected information about diabetic complications and cardiovascular risk factors and measured the coronary heart disease risk in these patients.

Results

In the year 2000, the standardized cumulative incidence and prevalence of known Type 2 diabetes were 5.0 per 1000 (CI 95%: 4.9–5.1) and 4.6% (CI 95%: 4.5–4.7) respectively. Macroangiopathy was the most frequent complication both in the newly diagnosed (21.6%) and previously known Type 2 diabetic patients (33%). Total cholesterol ≥5.17 mmol/l and LDL cholesterol ≥2.58 mmol/l were found in 75% and 90% of newly diagnosed and 65% and 85% of previously diagnosed Type 2 diabetic patients respectively. Of the Type 2 diabetic patients 42% were obese and 80% had high blood pressure. More than 55% of the men compared with 44% of the women with Type 2 diabetes had high or very high risk of coronary heart disease (p<0.05).

Conclusion/interpretation

We report new epidemiological data on known Type 2 diabetes in the Basque Country. These patients have a high frequency of cardiovascular risk factors causing a high coronary heart disease risk.
Literature
1.
Javitt JC, Yen-Pin Chiang YP (1995) Economic Impact of Diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH (eds) Diabetes in America, 2nd edn. National Diabetes Data Group of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, pp 601–611
2.
American Diabetes Association (1998) Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 31:296–309
3.
Selby JV, Ray GT, Zhang D, Colby CJ (1997) Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 20:1396–1402PubMed
4.
Geiss LS, MA, Herman WH, Smith PJ (1995) Mortality in non-insulin-dependent diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH (eds) Diabetes in America, 2nd edn. National Diabetes Data Group of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, pp 233–257
5.
Stamler J, Vaccaro O, Neaton JD, Wenworth DW (1993) Diabetes, other risk factors, and 12-Yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434–443PubMed
6.
Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234PubMed
7.
Turner RC, Millns H, Neil HA et al. (1998) Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23). BMJ 316:823–828PubMed
8.
Cockram C, Alberti G, Allgot B, Aschner P, Dwyer T, Haffner S, Mbanya JC, McLaughlin C, Mohan V (2001) Diabetes and cardiovascular diseases: time to act. Report of the International Diabetes Federation (IDF), Brussels
9.
Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention (1998) Prevention of coronary heart disease clinical practice. Eur Heart J 19:1434–1503PubMed
10.
Renders CM, Valk GD, Griffin SJ, Wagner EH, Van Eijk JT, Assendelft WJJ (2001) Interventions to improve the management of diabetes in primary care, outpatient, and community settings. Diabetes Care 24:1821–1833
11.
Chauvin P (1994) Constitution and monitoring of an epidemiological surveillance network with sentinel general practitioners. Eur J Epidemiol 10:477–479PubMed
12.
Green LA, Wood M, Becker L et al. (1984) The Ambulatory Sentinel Practice Network: purpose, methods, and policies. J Fam Pract 18:275–280PubMed
13.
Van Casteren V, Leurquin P (1992) Eurosentinel: development of an international sentinel network of general practitioners. Methods Inf Med 31:147–152PubMed
14.
Manuguerra JC, Mosnier A, Paget WJ (2001) Monitoring of influenza in the European network member countries from October to April 2001. Eur Surveill 6:127–133
15.
World Health Organization (1985). Diabetes mellitus: report of a WHO study group. Technical report series 727. WHO, Geneva
16.
Alberti KG, Zimmet PZ for the WHO Consultation (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Report of a WHO Consultation. Diabet Med 15:539–553PubMed
17.
Rose GA, Blackburn H, Gillum RF, Prineas RJ (1982) In: World Health Organization (eds) Cardiovascular survey methods. WHO Monograph Series no 56. World Health Organization, Geneva, pp 163–164
18.
Joint National Committee (1997) The sixth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 157:2413–2446PubMed
19.
Mayfield JA, Reibert GE, Sanders LJ, Janisse D, Pogach LM (1998) Preventive foot care in people with diabetes. Diabetes Care 21:2161–2179PubMed
20.
Third Report of the National Cholesterol Education Program (NCEP) (2001) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 285:2486–2497PubMed
21.
Culpepper L, Froom J (1988) The International Primary Care Network: purpose, methods, and policies. Family Med 20:197–201
22.
Chauvin P, Valleron A-J (1998) Participation of French general practitioners in public health surveillance: a multidisciplinary apoproach. J Epidemiol Community Health 52 [Suppl 1]:2S–8S
23.
Middelkoop BJ, Bohnen AM, Duisterhout JS, Pleumeekers HJ, Prins A (1994) A computerized network of general practices in Rotterdam, The Netherlands. Am J Public Health 84:1852–1853PubMed
24.
Matter HC, Cloetta J, Zimmermann H et al. (1995) Measles, mumps and rubella: monitoring in Switzerland through a sentinel network, 1986–1994. J Epidemiol Community Health 49 [Suppl 1]:4–8
25.
Capozzi C, Buonomo E, Fusiello S et al. (1997) A sentinel network of general practitioners for epidemiologic surveillance in Italy. Stud Health Technol Inform 43:211–214PubMed
26.
Fleming DM, Zambon M, Bartelds AI, Jong JC de (1999) The duration and magnitude of influenza epidemics: a study of surveillance data from sentinel general practices in England, Wales and the Netherlands. Eur J Epidemiol 15:467–473PubMed
27.
Maurice S, Pommereau X, Pueyo S et al. (1989) Epidemiological surveillance of suicides and attempted suicides in Aquitaine, south-west France, using an original computer network of sentinel general practitioners. J Epidemiol Community Health 43:290–292PubMed
28.
Schlaud M, Seidler A, Salje A et al. (1995) Organochloride residues in human breast milk: analysis through a sentinel practice nerwork. J Epidemiol Community Health 49 [Suppl 1]:17–21
29.
Green LA, Hames CG Sr, Nutting PA (1994) Potential of practice-based research networks: experiences from ASPN. Ambulatory Sentinel Practice Network. J Fam Pract 38:400–406PubMed
30.
Wens J, Van Casteren V, Vermeire E, Van Royen P, Pas L, Denekens J (2001). Diagnosis and treatment of type 2 diabetes in three Belgian regions. Registration via a network of sentinel general practices. Eur J Epidemiol 17:743–750CrossRefPubMed
31.
Ruwaard D, Gijsen R, Bartelds AI, Hirasing RA, Verkleij H, Kromhout D (1996) Is the incidence of diabetes increasing in all age-groups in The Netherlands? Results of the second study in the Dutch Sentinel Practice Network. Diabetes Care 19:214–218PubMed
32.
Thomas DR, Salmon RL, Westmoreland D, Palmer SR (1998) Surveillance of influenza in Wales: interpreting sentinel general practice rates using contemporaneous laboratory data. Opportunities and limitations. J Epidemiol Community Health 52 [Suppl 1]:28S–31S
33.
Green LA, Miller RS, Reed FM, Iverson DC, Barley GE (1993) How representative of typical practice are practice-based research networks? A report from the Ambulatory Sentinel Practice Network Inc (ASPN). Arch Fam Med 2:939–949PubMed
34.
Nutting PA, Baier M, Werner JJ, Cutter G, Reed FM, Orzano AJ (1999) Practice patterns of family physicians in practice-based research networks: a report from ASPN. Ambulatory Sentinel Pratice Network. J Am Board Fam Pract 12:278–284PubMed
35.
Bayo J, Sola C, García F, Latorre PM, Vazquez JA (1993) Prevalencia de la diabetes mellitus no dependiente de la insulina en Lejona (Vizcaya). Med Clin (Barc) 101:609–612
36.
Monclús JF, Álvarez JI. Arasa MJ, Aguilar C, Viñas JJ, Curto C (2001) Los criterios de la ADA-97, la prevalencia de diabetes mellitus y las comarcas más meridionales de Cataluña. Aten Primaria 27:178–182PubMed
37.
Franch Nadal J, Alvarez Torices JC, Alvarez Guisasola F, Diego Dominguez F, Hernandez Mejia R, Cueto Espinar A (1992) Epidemiología de la diabetes mellitus en la provincia de León. Med Clin (Barc) 98:607–611
38.
Tamayo-Marco B, Faure-Nogueras E, Roche-Asensio MJ, Rubio-Calvo E, Sanchez-Oriz E, Salvador-Olivan JA (1997) Prevalence and impaired glucose in Aragón, Spain. Diabetes Care 20:534–536PubMed
39.
Serna MC, Madrid M, Cruz I, Gasco E, Ribelles M, Serra Li (1999) Estimación de la prevalencia de diabetes mellitus en seis comarcas de la provincia de Lleida. Endocrinología 46:83–86
40.
Pallardo Sanchez LF, Ferre C, Puertas L, Pallardo Peinado LF (1980) Prevalencia de diabetes conocida en la población rural española en 1978. Rev Clin Esp 159:243–249PubMed
41.
Calle Pascual AL, Gomez Ballesteros V, Leon Carralafuente E (1988) Prevalencia de diabetes mellitus en la provincia de Guadalajara. Med Clin (Barc) 90:40
42.
Vila LL, Subirats E, Vila T, Margalef N, Cardona M, Vallesacar R (1994) Prevalencia de diabetes en la Cerdanya (comarca del Pirineo Oriental). Endocinología 41:305–309
43.
Muniz J, Hervada J, Juane R, Lopez Rodriguez I, Castro Beiras A (1995) Prevalence of diabetes mellitus in the population aged 40–69 years in Galicia, northwest Spain. Diebetes Res Clin Pract 30:137–142CrossRef
44.
Castell C, Tresserras R, Serra J, Goday A, Lloveras G, Salleras L (1999) Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study. Diabetes Res Clin Pract 43:33–40PubMed
45.
Vazquez JA, Gaztambide S, Soto-Pedre E (2000) Estudio prospectivo a 10 años sobre la incidencia y factores de riesgo de diabetes mellitus tipo 2. Med Clin (Barc) 115:534–539
46.
Pablos-Velasco PL de, Martinez-Martin FJ, Rodriguez-Perez F, Ania BJ, Losada A, Betancor P (2001) The Guia Study. Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population—comparison of the 1997 ADA and the 1985 WHO criteria. The Guia Study. Diabet Med 18:235–241PubMed
47.
Botas P, Delgado E, Castaño G, Díaz de Greñu C, Prieto J, Díaz FJ (2002) Prevalencia de diabetes mellitus e intolerancia a la glucosa en población entre 30 y 75 años en Asturias (España). Rev Clin Esp 202:421–427PubMed
48.
Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP (2001) The continuing epidemics of obesity and diabetes in the United States. JAMA 286:1195–1200PubMed
49.
Garancini M (1996) Age-specific incidence and duration of known diabetes. The Cremona Study. Diabetes Care 19:1279–1282PubMed
50.
51.
Figuerola D, Recasens A, Castell C et al. (1992) La asistencia al diabético en Cataluña. Estudio en una muestra de población. Med Clin (Barc) 99:90–95
52.
Mur T, Franch J, Morato J, Mena A, Villarubias M, Llobera A (1995) Macroangiopatia en la diabetes tipo II. El estudio Raval Sud. Aten Primaria 16:67–72PubMed
53.
Morató J, Franch J, Carrillo R, Via M, Herrera A, Valerio LI (1995) Cronología de las complicaciones en la diabetes del adulto. El estudio Raval Sud. An Med Interna 12:431–437PubMed
54.
Fernandez de Mendiola Espino J, Iza Padilla A, Lasa Beitia I, Ibanez Perez F, Aguirrezabala Jaca JR, Aizpuru Barandiaran M et al. (1996) Evaluación de la población diabética tipo II atendida en un equipo de atención primaria. Aten Primaria 17:432–438PubMed
55.
Goicolea I, Mancha A, Perez B, Villar G, Ugarte E, Vazquez JA (1996) Prevalencia de complicaciones de la diabetes en un area sanitaria de Vizcaya. Endocrinología 43:337–341
56.
Lara N, Franch J, Morató J, Egido A, Puig J, Castillejo J (1996) La dislipemia en la diabetes tipo II ¿Un factor de riesgo para la macroangiopatía? Aten Primaria 18:17–24
57.
Robles NR, Cid MC, Roncero F, Pizarro JL, Sánchez-casado E, Pérez-Miranda M (1996) Incidencia de nefropatía diabética en la provincia de Badajoz durante el periodo 1990–1994. An Med Interna 13:572–575PubMed
58.
Gonzalez-Clemente JM (1997) Diabetes mellitus no dependiente de insulina: asistencia en un area de Barcelona. Med Clin (Barc) 108:91–97
59.
Esmatjes E, Goicolea I, Cacho L, Pablos PL de, Rodríguez R, Roche MJ (1997) Nefropatía en la Diabetes mellitus tipo 2: prevalencia en España. Avances Diabetol 13:29–35
60.
Cabezas Cerrato J (1998) The prevalence of clinical diabetic polineuropathy in Spain: a study in primary care and hospital clinic groups. Diabetologia 41:1263–1269PubMed
61.
Bundó M, Aubá J, Vallés R, Torner O, Perez AM, Massons J (1998) Arteriopatía en la diabetes mellitus tipo 2. Aten Primaria 22:5–10PubMed
62.
Zancada F, Mena P, Campillo JE, Hernández R, Perez-Aloe MT (1999) Factores de riesgo vascular en la diabetes mellitus no insulinodependiente. Correlación entre albuminuria y hemoglobina glicada. An Med Interna 16:181–185PubMed
63.
Diabetes Draftin Group (1985) Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The Word Health Organization Multinational Study of Vascular Disease in Diabetes. Diabetologia 28:615–640
64.
Chi ZS, Lee ET, Lu M, Keen H, Bennet PH, the WHO Multinational Study Group (2001) Vascular disease prevalence in diabetic patients in China: standarised comparison with the 14 centres in the WHO multinational study of vascular disease in diabetes. Diabetologia 44 [Suppl 2]:82–86
65.
UKPDS Group (1990) UK prospective diabetes study 6. Complications in newly-diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Research 13:1–11PubMed
66.
Uusitopa M, Siitonen O, Pyorala K, Aro a, Hersio K, Penttila I, Vouitilainem E (1985) The relationship of cardiovascular risk factors for the prevalence of coronary heart disease in newly-diagnosed Type II (non-insulin-dependent) diabetes. Diabetologia 28:653–659
67.
Medical Research Council Working Party (1985) MRC trial of treatment of mild hypertension. Principal results. BMJ 291:97–104PubMed
68.
Beach KW, Strandness DE (1980) Arteriosclerosis and associated risk factors in insulin-dependent and non-insulin dependent diabetes. Diabetes 29:882–888PubMed
69.
Aro A, Voulainen E, Uusutupa M, Siitonen O, Korhonen T, Pyrola K (1981) Abnormalities of serum and lipoprotein lipids in newly-diagnosed type 2 diabetes. Diabetologia 21:244–260
70.
Santen RJ, Willis PW, Fajans SS (1972) Atherosclerosis in diabetes mellitus. Correlations with serum lipid levels, adiposity and serum insulin levels. Arch Intern Med 130:833–843
71.
Hernández JM, Costa B, Diabetes Study Group (ABS de Falset) (1991) Diagnostico de salud de la población diabética en la comarca del Priorat (Tarragona). Aten Primaria 8:668–674
72.
Calle Pascual AL, Calle Hernandez JR (1993) Factores de riesgo cardiovascular y tratamiento con insulina en pacientes diabéticos tipo II en quienes ha fracasado el tratamiento con hipoglucemiantes orales. Med Clin (Barc) 101:165–167
73.
Baena JM, Oller M, Martin R, Nicolau N, Altes A, Iglesias C (1999) Impacto de los nuevos criterios diagnósticos propuestos por la Asociación Americana de Diabetes (ADA 97) sobre la prevalencia diagnóstica de diabetes mellitus tipo 2. Aten Primaria 24:97–100PubMed
74.
Serna MC, Madrid M, Cruz I, Gasco E, Ribelles M, Serra LI (1999) Estimación de la prevalencia de diabetes mellitus en seis comarcas de la provincia de Lleida. Endocrinología 46:83–86
75.
American Diabetes Association (2001) Management of dyslipemia in adults with diabetes. Diabetes Care 24 [Suppl 1]:S58–S51
76.
Pyorala K, Laasko M, Uusitupa M (1987) Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 3:463–524PubMed
77.
Jarret RJ (1992) Risk factors for coronary heart disease in diabetes mellitus. Diabetes 41 [Suppl 2]:1–3
78.
Fuller JH, Stevens LK, Wang SL, the WHO Multinational Study Group (2001) Risk factors for cardiovascular mortality and morbidity: the WHO multinational study of vascular disease in diabetes. Diabetologia 44 [Suppl 2]:S54–S64
79.
Evans JMM, Wang J, Morris AD (2002) Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ 324:939–944CrossRefPubMed
Metadata
Title
Incidence, prevalence and coronary heart disease risk level in known Type 2 diabetes: a sentinel practice network study in the Basque Country, Spain
Authors
Dr. J. M. Arteagoitia
M. I. Larrañaga
J. L. Rodriguez
I. Fernandez
J. A. Piniés
Publication date
01-07-2003
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 7/2003
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1137-1

Other articles of this Issue 7/2003

Diabetologia 7/2003 Go to the issue

Article

Effects of insulin on long-term potentiation in hippocampal slices from diabetic rats

Observation

Lack of association between gene variants in the ALMS1 gene and Type 2 diabetes mellitus

Observation

Long-term hyperglycaemia decreases vascular fraction of extracellular superoxide dismutase

Article

Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy

Article

Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meta-analysis of 27 studies

Article

Genetic variation of the platelet- surface integrin GPIIb-IIIa (PIA1/A2-SNP) shows a high association with Type 2 diabetes mellitus
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits